| Phase 19 trials |
|
Phase 1
|
NCT06610890 |
Dec 2024 → Jan 2025 |
psoriasis |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06380153 |
May 2024 → Apr 2025 |
psoriasis |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06376474 |
Apr 2024 → Dec 2025 overdue |
psoriasis |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT05941247 |
Jul → Aug 2023 |
— |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT05468645 |
Jul → Sep 2022 |
— |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT04837235 |
Apr → Aug 2021 |
psoriasis |
Tianjin Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT03577626 |
Oct → Nov 2018 |
psoriasis |
Tianjin Hemay Bio-Tech Co., Ltd |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT03570346 |
Jul → Oct 2018 |
psoriasis |
Tianjin Hemay Bio-Tech Co., Ltd |
Unknown
|
No outcome recorded
|
|
Phase 1
|
NCT03007810 |
Dec 2016 → Jun 2018 |
psoriasis |
Tianjin Hemay Bio-Tech Co., Ltd |
Completed
|
No outcome recorded
|
| Phase 25 trials |
|
Phase 2
|
NCT07314242 |
Jan 2026 → Dec 2027 expected |
chronic obstructive pulmonary disease |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05769946 |
Nov 2022 → Jan 2024 |
atopic eczema |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT05486104 |
Nov 2022 → Dec 2026 expected |
ulcerative colitis |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT04609397 |
Nov 2020 → Apr 2022 |
Behcet disease |
Tianjin Hemay Pharmaceutical Co., Ltd |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT04102241 |
May 2019 → Oct 2020 |
psoriasis |
Tianjin Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|
| Phase 33 trials |
|
Phase 3
|
NCT07650942 |
Jun 2026 → May 2028 expected |
ulcerative colitis |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT06145893 |
Nov 2023 → May 2026 overdue |
Behcet disease |
Ganzhou Hemay Pharmaceutical Co., Ltd |
Recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT04839328 |
Jan → Oct 2022 |
psoriasis |
Tianjin Hemay Pharmaceutical Co., Ltd |
Completed
|
No outcome recorded
|